|
|
|
|
|
|
|
|
|
|
This Advancing RNA discussion will be a deep dive into the world of plasmid sourcing and quality considerations. What quality attributes matter the most for producing the desired quality of mRNA? What are the current gaps in our knowledge of plasmid quality, and how are we as an industry striving to close these gaps? Register today and find out.
|
|
|
|
|
|
Video | MilliporeSigma
|
Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by experience, helps reduce risk across development.
|
|
|
|
|
|
Webinar | Lonza
|
This panel session features a decade-long story of partnership in bringing two life-changing gene therapies to market successfully, offering key insights for autologous cell therapy developers.
|
|
|
|
|
|
Video | Thermo Fisher Scientific
|
PFAS-free bioreactor film technology provides proven biocompatibility and strength across workflows while simplifying validation and reducing material variability for compliant operations.
|
|
|
|
|
|
Video | MaxCyte, Inc.
|
A high-throughput electroporation platform enables rapid optimization across 96 samples, supporting gene editing and non-viral CAR-T development from discovery through GMP-scale manufacturing.
|
|
|
|
|
|
Webinar | Invetech
|
Explore a system that uses a gentle elutriation process to give manufacturers a cleaner cell population to begin cell therapy production processes, such as CAR-T therapy manufacturing.
|
|
|
|
|
|
Video | Cell & Gene
|
In Episode 135 of Cell & Gene: The Podcast, Host Erin Harris talks to Sonal Gupta, MD, Ph.D., Chief Medical Officer of CoRegen, about the company's novel approach to treating solid tumors by engineering regulatory T cells (Tregs) rather than conventional effector immune cells.
|
|
|
|
|
|
|
|
|
|
Webinar: Annex 1 in Practice: Turning CCS Into Cleanroom Design
|
How can facility design help prevent contamination before it threatens product quality? This AES webinar explores how EU GMP Annex 1 and a proactive Contamination Control Strategy (CCS) can shape cleanroom design, airflow, barrier technology, personnel and material flow, and aseptic processes. Learn how embedding contamination control from concept through operation can reduce regulatory risk and support inspection-ready manufacturing facilities. Click here to learn more.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
